Keyphrases
6-mercaptopurine (6-MP)
61%
6-thioguanine nucleotides
15%
Acute Lymphoblastic Leukemia
72%
Adjusted Odds Ratio
15%
Anal Incontinence
37%
Cardiotocography
20%
Childhood Acute Lymphoblastic Leukemia
85%
Confidence Interval
26%
Cystic Fibrosis
20%
Estimation Method
15%
Hazard Ratio
15%
High Risk
25%
High-dose Methotrexate (HD-MTX)
20%
In Situ Simulation
20%
Intermediate Risk
21%
Maintenance Therapy
93%
Mercaptopurine
25%
Methotrexate
32%
Methyltransferase Activity
17%
Midwives
15%
Multiple Breath Washout
30%
Obstetric Anal Sphincter Injuries (OASIS)
50%
Obstetrics
16%
Odds Ratio
18%
Pediatric Hematology
15%
Pregnant Women
20%
Preterm Delivery
16%
Randomized Controlled Trial
22%
Relapse Risk
20%
Risk Factors
18%
Second Cancer
20%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
16%
Thiopurine Methyltransferase
40%
Twin Pregnancy
20%
White Blood Cell Count
21%
Working Diagnosis
15%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Breathing
20%
Cardiotocography
20%
Cell Count
18%
Cesarean Section
16%
Cohort Analysis
41%
Comorbidity
20%
Feces Incontinence
37%
First Trimester Pregnancy
20%
Hazard Ratio
16%
Internal Anal Sphincter
50%
Leukocyte
26%
Maintenance Therapy
61%
Mercaptopurine
46%
Methotrexate
34%
Obstetrics
65%
Odds Ratio
37%
Quality of Life
16%
Randomized Controlled Trial
22%
Second Cancer
20%
Thiopurine Methyltransferase
22%
Vaginal Ultrasonography
20%